Top compounds associated with response to CDCA2


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan CCLE pan-cancer AAC 0.19 0.0003
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0003
mRNA ML083 CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA NSC-207895 GDSC1000 pan-cancer AAC 0.12 0.0003
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.12 0.0006
mRNA CHIR-99021 GDSC1000 pan-cancer AAC -0.11 0.0007
mRNA FTI-277 GDSC1000 pan-cancer AAC -0.12 0.0007
mRNA niclosamide CTRPv2 pan-cancer AAC 0.12 0.0007
Download CSV